MercoPress, en Español
Get our news on your inbox! Suscribe x
Montevideo, September 23rd 2023 - 03:52 UTC
AstraZeneca has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after a suspected serious adverse reaction in a study participant, health news website Stat News reported on Tuesday.
Get our news on your inbox!